About Blindness Preventment and Treatment Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Blindness Preventment and Treatment Department
During the past decade, Blindness Preventment and Treatment Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
2013-07-17
2015-05-14
Completed
599
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
2014-07-29
2018-02-09
Terminated
253
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
2014-08-01
2016-12-01
Completed
1,152
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
2015-09-15
2020-11-18
Completed
620
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
2015-12-08
2018-01-05
Terminated
701
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Blindness Preventment and Treatment Department"
#1 collaborator was "Orbis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Blindness Preventment and Treatment Department
According to Clinical.Site data, the most researched conditions in "Blindness Preventment and Treatment Department" are
"Glaucoma" (3 trials) and "Adherence" (1 trials). Many other conditions were trialed in "Blindness Preventment and Treatment Department" in a lesser frequency.
Clinical Trials Intervention Types at Blindness Preventment and Treatment Department
Most popular intervention types in "Blindness Preventment and Treatment Department" are "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Multifaceted education" (1 trials), "SLT laser" (1 trials) and "SMS and free eye drops" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Blindness Preventment and Treatment Department
The vast majority of trials in "Blindness Preventment and Treatment Department" are
3 trials for "All" genders.
Clinical Trials Status at Blindness Preventment and Treatment Department
Currently, there are NaN active trials in "Blindness Preventment and Treatment Department".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Blindness Preventment and Treatment Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Blindness Preventment and Treatment Department, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".